Group items tagged

In the ever-evolving world of clinical treatments, a pharmaceutical industry leader faced a challenge: adapting its messaging to meet the changing needs of European physicians. We, at Jasper Colin, stepped in to help them create a strategic positioning for their new drug, ensuring it stood out in a competitive landscape. Our strategic positioning efforts gave the drug a competitive edge, making it a preferred choice among European physicians.

Did you know? The global medical imaging market is set to soar to $63.5 billion by 2030, with a staggering CAGR of 6.5%! The market growth can be attributed to the rising prevalence of chronic diseases such as cancer and cardiovascular diseases, thereby increasing the demand for sophisticated diagnostic imaging technologies.

Jasper Colin's HOSPiDEX™ 2022 surveyed about 1500 patients and selected healthcare providers to understand the current patient flow in Specialty Hospitals across the US. Findings revealed the importance of specialized training, equipment, and communication to improve patient outcomes in these settings.

The high prescription drug spending in the US compared to other developed nations is a complex issue influenced by various factors such as drug prices, healthcare system structures, and policy decisions. Understanding these components is essential for policymakers, healthcare providers, and consumers in addressing the complex issue of prescription drug spending and exploring potential avenues for cost containment and affordability.

Healthcare worker turnover is a pressing issue, but hospitals are taking proactive steps to address it. By prioritizing employee retention and offering premium benefits, they're working to ensure a stable and satisfied workforce. High turnover in healthcare isn't new, but the numbers are hitting harder than ever post-COVID. With 62% of hospitals witnessing a nurse turnover uptick, it's clear the waves from the pandemic are still crashing ashore.